+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy and Safety of Proton Pump Inhibitors in the Long-Term Aspirin Users: A Meta-Analysis of Randomized Controlled Trials



Efficacy and Safety of Proton Pump Inhibitors in the Long-Term Aspirin Users: A Meta-Analysis of Randomized Controlled Trials



American Journal of Therapeutics 24(5): E559



Long-term aspirin use in cardiovascular disease prevention may result in gastrointestinal bleeding. Although proton pump inhibitors (PPI) have been shown to reduce the risks of peptic ulcers and dyspeptic symptoms in long-term aspirin users in the randomized controlled trials, there are safety concerns about the long-term use of PPI. What is the safety and efficacy of PPI in patients using aspirin in long term for prevention of cardiovascular diseases and stroke? We searched MEDLINE, EMBASE, CENTRAL, CINAHL, ProQuest, and relevant references from inception through February 2015, and used random-effects model for meta-analysis. A total of 10 publications from 9 studies (n = 6382) were included in the meta-analysis. Compared with control, PPI reduced the risks of peptic ulcers [risk ratio (RR): 0.19; 95% confidence interval: 0.13-0.26; P < 0.00001], gastric ulcers [0.24 (0.16-0.35); P < 0.00001], duodenal ulcers [0.12 (0.05-0.29); P < 0.00001], bleeding ulcers [0.22 (0.10-0.51); P = 0.0004], and erosive esophagitis [0.14 (0.07-0.28); P < 0.00001]. PPI increased the resolution of epigastric pain [1.13 (1.03-1.25); P = 0.01], heartburn [1.24 (1.18-1.31); P < 0.00001], and regurgitation [1.26 (1.13-1.40); P < 0.0001], but did not increase the risks of all-cause mortality [1.72 (0.61-4.87); P = 0.31], cardiovascular mortality [1.80 (0.59-5.44); P = 0.30], nonfatal myocardial infarction/ischemia [0.56 (0.22-1.41); P = 0.22], ischemic stroke/transient ischemic attack [1.09 (0.34-3.53); P = 0.89] and other adverse events. The PPI seems to be effective in preventing peptic ulcers and erosive esophagitis and in resolution of dyspeptic symptoms without increasing adverse events, cardiac risks or mortality in long-term aspirin users.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059666547

Download citation: RISBibTeXText

PMID: 28763306

DOI: 10.1097/mjt.0000000000000637


Related references

Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology 23(1): 11-19, 2017

Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Critical Care 20(1): 120, 2016

Short-term and Long-term Postoperative Safety of Off-Pump versus On-Pump Coronary Artery Bypass Grafting for Coronary Heart Disease: A Meta-analysis for Randomized Controlled Trials. Thoracic and Cardiovascular Surgeon 63(4): 319-327, 2015

The efficacy and safety of aspirin plus dipyridamole versus aspirin in secondary prevention following TIA or stroke: a meta-analysis of randomized controlled trials. Journal of the Neurological Sciences 332(1-2): 92-96, 2013

Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. Journal of Affective Disorders 223: 41-48, 2017

Long-term efficacy and safety of carotid artery stenting versus endarterectomy: A meta-analysis of randomized controlled trials. Plos one 12(7): E0180804, 2017

Long-term efficacy and safety of varenicline for smoking cessation a systematic review and meta-analysis of randomized controlled trials. Journal of Public Health 20(4): 355-365, 2012

Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up. Pharmacological Research 81: 64-73, 2014

Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clinical Gastroenterology and Hepatology 5(2): 178, 2007

Long-term efficacy and safety of proprotein convertase subtilisin/kexin 9 monoclonal antibodies: A meta-analysis of 11 randomized controlled trials. Journal of Clinical Lipidology 12(2): 277-291.E3, 2018

Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials. Journal of Cancer Research and Clinical Oncology 145(7): 1795-1809, 2019

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis. International Journal of Clinical Practice 69(10): 1088-1111, 2015

Proton pump inhibitors in the treatment of peptic ulcer bleeding A Cochrane Collaboration meta-analysis of randomized controlled Trials. American Journal of Gastroenterology 98(9 Suppl.): S49-S50, 2003

Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies. Expert Opinion on Drug Safety 18(3): 163-172, 2019

Intravenous proton pump inhibitors for peptic ulcer hemorrhage Meta-analysis of randomized controlled trials allowing endoscopic treatment. Gastroenterology 120(5 Suppl. 1): A 248, 2001